The regulation of cell migration is a key factor for the dissemination of metastatic cells during tumor progression. Aquaporins are membrane channels which allow transmembrane fluxes of water and glycerol in cells in a variety of mammalian tissues. Here, we show that AQP3, which has been incriminated in cancer progression, is regulated by the AhR, or dioxin receptor. AhR is a transcription factor which is triggered in response to environmental pollutants and it has been shown to regulate several cellular processes including cell migration and plasticity. In vivo, upon exposure to the aryl hydrocarbon receptor (AhR) ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the expression of AQP3 is increased significantly in several murine tissues including the liver. In vitro, treatment of human HepG2 cells with TCDD also increased the expression of AQP3 mRNA and protein. These effects resulted from the activation of AhR as shown by RNA interference, chromatin immunoprecipitation and the use of several AhR ligands. Immunofluorescence and real-time analysis of cell migration (XCelligence) demonstrated that knockdown of AQP3 mRNA using small interfering RNA impairs the remodeling of cell shape and the triggering of cell migration that is induced by TCDD. Our work reveals, for the first time, a link between exposure to pollutant and the induction of an aquaporin which has been suspected to play a role during metastasis.
The aryl hydrocarbon receptor (AhR) is a member of the Per-ARNT-Sim family of proteins and has been described primarily as a sensor of xenobiotics which include dioxins, polycyclic aromatic hydrocarbons, and polychlorinated biphenyls. It is a transcription factor which positively regulates the expression of xenobiotic metabolism enzymes which allow for the detoxication of AhR ligands (Coumoul et al., 2001) . Although this elegant mechanism has been characterized extensively, other functions of the AhR have subsequently emerged during the last decade due to large-scale studies or the use of knock-out models (Barouki et al., 2007; Ma et al., 2009) .
Recently, we and others have shown that the AhR regulates cell migration and invasion (Barouki and Coumoul, 2010; Carvajal-Gonzalez et al., 2009; Rico-Leo et al., 2013; Rey-Barroso et al., 2014) . Interestingly, altered migration is observed not only upon treatment of primary cells or cell lines with AhR ligands but also in knockout cell lines as the result of the absence of the receptor. In vivo studies also suggest that the AhR is a critical regulator of cell migration and invasion (CarvajalGonzalez et al., 2009; Pierre et al., 2014) . We have identified several of the cellular targets of the AhR pathway which are involved in this regulation. Some of them are critical mainly for cell proliferation (Son of Sevenless 1 or Sos1) whereas others affect cell migration (Human Enhancer of Filamentation 1 or HEF1, also known as Cas-L or NEDD9) (Bui et al., 2009; Pierre et al., 2011) . In addition to the well described genomic pathway, AhR may act via non-genomic pathways involving Src and focal adhesion kinase (FAK) to regulate cell morphology and migration. The genomic and non-genomic pathways could converge functionally since they have common targets such as the Hef1 protein, which is part of the integrin/FAK signaling pathway. However, although this pathway appears to be necessary, there is no evidence to show that it is sufficient by itself to mediate the effects of dioxin.
Our whole genome transcriptome analyses also have demonstrated that the expression of aquaporin 3 (AQP3) is increased significantly in HepG2 cells following their exposure to dioxin. Aquaporins are a family of membrane water/glycerol channels which are involved in physiology and pathophysiology (Verkman et al., 2014) . Their structures allow fast transfer of water and small molecules (including glycerol for some members of the family) across biological membranes. In microorgansims, these proteins regulate the adaptation to osmotic shock and rapid freezing. In mammals, which are the organisms the most studied, they regulate cell behavior (migration, proliferation), metabolism and transport (Verkman et al., 2014) . Indeed, recently, a role in vivo was demonstrated for AQP in cell migration and, potentially, in cell metastasis (Verkman et al., 2014) .
In this article, we show that AQP3 is a transcriptional target of the AhR and its ligands both in vivo in mice and in vitro, in human cells. Moreover, we show that the induction of AQP3 is critical for TCDD-induced morphological and migratory changes.
MATERIALS AND METHODS
Cell culture. Human hepatoblastoma HepG2 and mammary MDA-MB-231 cells were cultured at 37 C in Dulbecco's minimal essential medium (DMEM) complemented with nonessential amino acids, supplemented with 10% fetal bovine serum, 200 U/ ml penicillin, 50 mg/ml streptomycin (Invitrogen, CergyPontoise, France), and 0.5 mg/ml amphotericin B (Bristol-Myers Squibb Co., Stamford, Connecticut) in a humidified atmosphere in 5% CO 2 . One day before exposure to various concentrations of TCDD, the cells were cultivated in DMEM without phenol red supplemented with 3% charcoal-treated (desteroidized) calf serum and maintained in this medium during all treatments. The human epidermal keratinocytes YF23 were cultured according to Vanhoutteghem and Djian (2004) . TCDD was purchased from LCG Promochem (Molsheim, France). Benzo(a)pyrene, 3-methylcholanthrene, resveratrol, and quercetin were purchased from Sigma-Aldrich (St Louis, Missouri).
Animals, treatments, and tissue extraction. Male C57BL/6 J mice (Janvier, France) were housed in temperature and humiditycontrolled rooms, kept on a 12-h light-dark cycle, and provided unrestricted amounts of food and water chow diet (V153x R/M-H, Ssniff GmbH). The animal treatment protocol was approved by the bioethics committee of Paris Descartes University (authorization no. CEEA34.MA.003.12.) and all animals received humane care according to the Guide for the Care and the Use of Laboratory Animals (NIH publication 86-23 revised 1985) .
Male mice (7 weeks old, n ¼ 5) were injected IP with 200 ml of either TCDD (25 mg/kg body weight) or the vehicle (corn oil). This amount of TCDD leads, after 48 h, to a blood concentration of TCDD ranging from 100 to 1000 ppt according to Emond's physiologically based pharmacokinetic model. Those concentrations mimic a high TCDD contamination. The treatment consisted of injections of TCDD or corn oil on day 0 and 7 and the mice were killed on day 14. The tissues (skin, liver, kidney, heart, lung, cerebellum, and cortex) were removed immediately and frozen in liquid nitrogen. . Protein-DNA complexes were eluted by adding 400 ml of elution buffer (1% SDS, 0.1 M NaHCO3, and protease inhibitors), 20 min at room temperature with rotation (input samples were included). The cross-linking was reversed by adding NaCl to a final concentration of 0.2 M and incubating overnight at 65 C. The DNA was purified using a PCR purification kit (Cat 28106, Qiagen) and eluted in 25 ml. We used the UCSC Genome Bioinformatics site (http:// genome.ucsc.edu) and the MatInspector software (http://www. genomatix.de/online_help/help_matinspector/) to characterize a potential XRE inside the human AQP3 promoter sequence:
Chromatin immunoprecipitation (ChIP
A potential XRE site was located in the region (-1052/-887: TGGG CATGGTGGTGTGCACCTGTAATCCCAGCTAATCGGGAGGCTGAAGC AGGAGAATCACTTGAACCTGGGAGGTGGAGGTTGCAGGGAGCCGA GATCACGCCATTGCACTCCACCTAGGCGACAGAGAGAGACTCCGTC TAAAAAAAAAAAAGAGACAGACTC) and is represented in bold and italics (À954/À950)ChIP DNA was analyzed by quantitative PCR using the specific primers covering the region -1052-887 bp of the human AQP3 promoter (forward primer: 5 The relative amounts of mRNA were estimated using the delta-delta Ct method with RPL13A as the reference for human samples and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for the murine samples.
Western blot. Cells were scraped into M-PER Mammalian Protein Extraction Reagent containing a protease and phosphatase inhibitor cocktail (Sigma) and clarified by centrifugation. For western blots, equal amounts of total protein were separated by SDS-PAGE and transferred onto nitrocellulose membranes. Blocking of the membrane was done in 0.2% I-Block (life technologies) solution containing 0.1% Tween-20 for 1 h at room temperature followed by incubation overnight at 4 C with primary antibodies AQP3 (Ab125219, Abcam Paris, France) and actin (loading control, ab8226, Abcam Paris, France). After 3 washes with 0.1% Tween-20 PBS, the membrane was incubated with the corresponding alkaline phosphatase-conjugated secondary antibody or IRdye 800 and IRdye 680 (Sciencetec). After the final washes, signals were assessed using the Odyssey Infrared Imager (LI-COR).
Transfection with siRNA. One day before transfection, HepG2 cells (4 Â 10 5 cells per well) were seeded into 6-well plates. Twentyfour hours later, the medium was replaced by DMEM without phenol red supplemented with 3% charcoal-treated (desteroidized) calf serum and cells were then transfected with 5 nM siRNA, using the HiPerfect transfection reagent (Qiagen) according to the manufacturer's protocol. For experiments involving AQP3, after 8 h of incubation at 37 C, the medium was replaced and the cells were treated or not with 25 nM TCDD. Seventy-2 h after transfection, purification of RNA and examination of thecellular immunofluorescence were carried out. SiRNA references (Qiagen) are: Hs_AQP3_5_HP Validated siRNA xCELLigence real-time cell analysis (RTCA) of migration. Cell migration was carried out using an xCELLigence RTCA DP instrument (ACEA Biosciences) which was placed in a humidified incubator at 37 C and 5% CO 2 . The experiments were performed using modified 16-well plates (CIM-16) with each well consisting of an upper and a lower chamber separated by a microporous membrane. Microelectrodes were attached to the underside of the membrane for impedance-based detection of migrated cells. HepG2 cells (50 000 cells per well) were seeded into CIM-16 plates (which are specifically used to measure cell migration) in DMEM without phenol red supplemented with 3% charcoaltreated (desteroidized) calf serum and were transfected with the siControl (siC) or the siAQP3 using the RNAi Max transfection reagent according to the protocol provided by the supplier (Life Technologies, Rockville, Maryland). The lower chambers contained media with 10% FBS in order to assess chemotactic migration. After 24 h of incubation at 37 C, the medium was replaced and the cells were treated, or not, with 25 nM TCDD. The impedance value of each well was automatically monitored by the xCELLigence system and expressed as a cell index value (CI). Higher CI values equate to more migration; the cells migrate from the upper chamber towards the lower chamber. The migration curves were monitored online of every 5 min during the 160 h of incubation and the slope of the migration curve was calculated using the RTCA 1.2 software. Each experiment was performed in triplicates.
Statistical analysis. The results arising from 3 independent experiments are expressed as the mean 6 SD (standard deviations). Statistical analysis was performed using successively the Mann-Whiteny's U test (nonparametric comparison of 2 independent series) or H Kruskal-Wallis's test (nonparametric comparison of k independent series) followed by a 1-factor ANOVA test (parametric comparison of k independent series). A value of P < .05 was considered statistically significant.
RESULTS
The Expression of AQP3 in Mice Is Upregulated Following Exposure to TCDD Exposure Our previous studies showed that TCDD and the AhR triggered cell migration (Bui et al. 2009 ). In order to identify putative targets involved in this process, we screened available microarray data (from our laboratory) for changes in gene expression following treatment of cell lines with dioxin (Diry et al. 2006) . The expression of AQP3 was found to be increased. Since aquaporins have been described as critical regulators of cell migration and potentially metastasis, we examined whether the expression of AQP3 is regulated by TCDD in several murine tissues. Figure 1 shows that whereas CYP1A1 (a TCDD target) expression is increased in all the organs examined (Fig. 1A) , the levels of AQP3 mRNA are significantly upregulated only in skin and in liver (Fig. 1B) .
AQP3 mRNA and Protein Levels Are Increased by TCDD
To decipher the mechanisms involved in this regulation, we examined the kinetics and dose-response characteristics following treatment with TCDD of HepG2 cells, which express the aryl hydrocarbon receptor (AhR). We found an increase in AQP3 mRNA expression that was significant after 8 h of exposure of cells to 25 nM TCDD treatment. This increase remained significant for longest periods of time tested (48 h, Fig. 2A) indicating that the AQP3 gene is a transcriptional target of dioxin. A significant induction of AQP3 expression was observed following exposure of cells, for either 24 or 48 h, to concentrations of TCDD in the range of 1-100 nM (Figs. 2B and C) . The amount of AQP3 protein was significantly increased following treatment for 24 or 48 h with 25 nM TCDD ( Figure 2D and Supplementary Fig. 1 ). We demonstrated that AQP3 mRNA is increased in liver but also in skin in TCDD-exposed mice; we then checked the expression of AQP3 mRNA in the human epidermal keratinocytes derived from the foreskin of a newborn (strain YF23) (Vanhoutteghem and Djian, 2004 ) and demonstrated that it was significantly increased following treatment for 48 h with 25 nM TCDD ( Supplementary Fig. 2 ).
The Induction of AQP3 Expression Depends Upon AhR
We next investigated the involvement of the AhR in the induction of AQP3 expression. Three other AhR ligands (3MC, BaP, and quercetine) were able to significantly increase the AQP3 mRNA expression albeit to different extents (Fig. 3A) .
Resveratrol increases the level of AQP3 and blocks the effects of TCDD. In a cell line which does not express a optimal AhR pathway (MDA-MB-231), AQP3 is not induced following exposure of cells for 48 h to 25 nM dioxin (Fig. 3B) . We then used RNA interference to decrease the levels of AhR in the HepG2 cells exposed or not to TCDD (Fig. 3C) . Following AhR knockdown, the increase in expression of both CYP1A1 (Fig. 3D) and AQP3 (Fig. 3E ) are significantly reduced following exposure of cells to TCDD. These results strongly suggest that the AhR is involved in mediating the effects of TCDD. Finally, using analysis by chromatin immunoprecipitation (ChIP), we found that AhR binds to the AQP3 promoter (which contains a potential XRE as identified by the MatInspector software located in À954/À950) of HepG2 cells exposed to 25 nM TCDD (Fig. 3F) .
We then investigated the function of AQP3 in HepG2 cells, specifically when its expression is triggered by TCDD. We used RNA interference to knockdown AQP3 mRNA levels by more than 60% (Fig. 4A, 75% with TCDD) . The level of CYP1A1 mRNA was not modified which suggests that this knockdown is specific (Fig. 4B) . Immunofluorescence was then used to investigate the morphological changes induced by exposure of cells to TCDD. Antibodies to actin and paxillin were used to examine, respectively, the cytoskeleton and focal adhesion sites. Cells exposed to TCDD had dramatically altered morphologies as seen previously (cell spreading, formation of focal adhesion sites). Remarkably, transfection of cells with siAQP3 blunted this effect (Fig. 4C) . Finally, we investigated global cellular attributes in another way. We used the xCELLigence system with specific plates (CIM plates) to measure cell invasion and migration. Cells exposed to TCDD had CI values that significantly increased over time, which suggests that cell invasion/migration was increased (Fig. 4D) . The use of RNA interference to reduce the induction, by TCDD, of expression of AQP3 impairs this effect. These results suggest that the induction of AQP3 is a required step in a molecular pathway that leads to changes in liver cell morphology and migration following exposure to TCDD.
DISCUSSION
In this study, we show that the expression of AQP3 can be regulated by the Ah Receptor (AhR), which, in turn, is activated by numerous exogenous and endogenous ligands. In line with our previous studies on Hef1 and Sos1 (Bui et al., 2009; Pierre et al., 2011; Tomkiewicz et al., 2013) , this regulation of AQP3 appears also critical for the migration of cancer cells exposed to AhR ligands, suggesting that several participants in the epithelialmesenchymal transition (EMT) are concomitantly upregulated or activated, which leads to cellular remodeling of focal adhesion sites (HEF1, FAK, Src), cell proliferation (SOS1), and migration (AQP3) (Bui et al., 2009; Pierre et al., 2011; Tomkiewicz et al., 2013 ). An epithelial cell undergoes EMT when it loses its epithelial markers and acquires mesenchymal markers; as a consequence, adhesion, and migration properties are changed. EMT has been described in physiological (gastrulation) and pathological (fibrosis) processes and is suspected to be involved in the formation of metastatic cells.
AQP3 is expressed in epithelia (oral, mammary gland) (Mobasheri and Barrett-Jolley, 2014; Poveda et al., 2014) . Its expression has been shown to be regulated not only by a number of physiological stimuli including epidermal growth factor (EGF) or hepatocyte growth factor (HGF) but also by cellular regulatory processes such as miRNA production (miR-874) Zhi et al., 2014) . The upregulation of AQP3 may be also related to epithelial-mesenchymal transition since AQP3 modulates cell migration and invasion and decreases the expression of E-Cadherin through activation of the PI3K (phosphoinositide 3-kinase)/AKT/SNAIL pathway (Chen et al., 2015) . The mechanism linking AQP3 to the PI3K pathway remains to be characterized.
AQP3 has been implicated in the regulation of cell migration in other systems. For example, a recent study using human skin samples showed that the expression of AQP3 increased following burn injury, specifically along the burn edge and that this expression contributes to burn healing (Sebastian et al., 2015) . Interestingly, it might be possible that a burn injury produces locally some polycyclic aromatic hydrocarbons which could activate the AhR and then induce AQP3. Peritoneal wound healing also depends on the expression of AQP3 which is, in this specific case, stimulated by transforming growth factor beta 1 (TGF-ß1), whose expression is also stimulated upon TCDD exposure in mice Ryu et al., 2012) .
The regulation of cell migration is also a critical process in the appearance of metastatic cells and AQP3 has been implicated in the migration of cancer cells using different models. This is the case for human mammary (stimulated by fibroblast growth factor 2) (Cao et al., 2013) , gastric (stimulated by c-Met or EGD) (Huang et al., 2010; Wang et al., 2012; Xu et al., 2011) colon and pancreatic cell lines (stimulated by EGF). These studies have been helpful showing that the PI3K/AKT and ERK (extracellular signal-regulated kinase 1/2) pathways are involved in the upregulation of the expression of AQP3. For example, the knockdown of AQP3 mRNA and protein in prostate cancer cell lines leads to a reduction of ERK1/2 signaling and matrix metalloprotease 3 (MMP3) secretion (Chen et al., 2015) .
Taking into consideration the diverse physiological and pathophysiological processes involving AQP3, we hypothesize that the regulation of this protein by the Aryl hydrocarbon Receptor (AhR) might be critical for AhR ligand-related pathologies including chloracne (a skin disease highly related to dioxin exposure), metabolic disorders (due to its expression in adipose tissues) and cancer. In particular, we hypothesize that AQP3 increases water transport at the proximity of the cell membrane thus allowing a reshaping of cellular protrusions, which are essential for cell migration. Ji et al. (2008) , showed that curcumin, an AhR ligand, impairs both the induction of AQP3 and cell migration in human ovarian CaOV3 cells. This is coherent with our hypothesis that each AhR ligand acts differently on the AhR; although the authors demonstrated that curcumin blocks the EGF pathway, it is also possible that it inhibits AhR signaling as this polyphenol is described as an antagonist of TCDD (Goué dard et al., 2003 (Goué dard et al., , 2004 Guyot et al., 2012 Guyot et al., , 2013 Juricek et al., 2014) . The regulation of AQP3 by the AhR might be even more complex, while taking in account the interplay between the receptor and the estrogen pathway. Indeed, Boverhof et al. (2008) , studied the inhibition of estrogen-mediated uterine gene expression responses by TCDD and show that ethinyl estradiol (EE) blocks Aqp3 mRNA expression in mice in the uterus. Moreover, Burns et al. (2013) , showed that exposure to TCDD during gestation, also blunted the adult uterine response to estradiol in mice; as a consequence, E2-induction of Aqp3 mRNA is also decreased by TCDD. Both studies strongly suggest that AQP3 is a target gene of the estrogen receptors (ER) and the aryl hydrocarbon receptor pathways. Interestingly, TCDD has been shown to display both proestrogenic or antiestrogenic properties according to the presence of estradiol, the tissue and the context (proestrogenic in case of an unbound state) (Ohtake et al., 2003) . One hypothesis would be that estrogen-responsive tissues positively responds to estradiol and negatively to TCDD regarding AQP3 (and probably other genes), while tissues such as skin or liver only respond to TCDD (but possibly in a complex involving the unbound ER).
Cancer phenotypes are dependent on the inflammatory and hypoxic characteristics of the tumor which also have been associated with the expression of AQP3. A recent study showed that AQP3 might be important in the regulation of inflammation: AQP3 is transcriptionally regulated by Notch signaling in keratinocytes. The Notch-AQP3 pathway (which involves a negative feedback loop) triggers the production of pro-inflammatory cytokines and its dysregulation is associated with the development of skin cancers (Guo et al., 2013) . Moreover, the overexpression of several AQPs in PC12 cells (rat pheochromocytoma) leads to the stabilization of hypoxia-induced factor-2 alpha (HIF-2 alpha), a transcription factor which positively regulates angiogenesis, glucose metabolism, and the acquisition of invasive properties (Galán-Cobo et al., 2013) . HIF-2 alpha acts through binding to ARNT, the transcriptional partner of the AhR.
In conclusion, we provide here the first evidence for a link between an environmental insult and the upregulation of expression of AQP3. While important from a toxicological point of view, there also may be pharmacological implications. Manipulation of the AhR pathway (using agonists or antagonists of the receptor) to increase or decrease the expression of AQP3 may be useful for skin (re)-hydration, wound healing and for regulating cancer progression.
